An FDA regulation requiring dramatically expanded disclosure of side effects and counterindications in direct-to-consumer drug ads would not, after Loper Bright, survive a legal challenge alleging that the agency is exceeding its statutory authority.

“Free markets flourish when the rule of law yields a predictable, proportionate, and uniform sentencing regime. Wrongdoers should be punished fairly—not arbitrarily.”—Zac Morgan, WLF Senior Litigation Counsel Click here to read WLF’s brief. (Washington, DC)—Washington Legal Foundation (WLF) today urged the U.S. Sentencing Commission to adopt amendments to that agency’s...

“The solutions recommended in this paper are crucial to stopping this growing threat to state attorney general authority. This is not a partisan issue—both Democratic and Republican attorneys general face the same legal threat in their states.”—Kansas Attorney General Kris Kobach, from the Foreword (Washington, DC)—Washington Legal Foundation today released...

Learn about the legislative & litigation strategies state AGs can use to stem cities' and counties' plaintiff-lawyer-driven incursions into their authority.

“Courts may not undermine the FAA’s pro-arbitration mandate by speculating about arbitrator impartiality.”—Cory L. Andrews, WLF General Counsel & Vice President of Litigation Click here for WLF’s brief. (Washington, DC)—Washington Legal Foundation (WLF) today urged the U.S. Supreme Court to review and reverse a decision by the U.S. Court of...

HIGHLIGHTS: 4 amicus filings – 2 victories – 1 regulatory comment – 6 publications NEW FILINGS – AMICUS BRIEFS Janssen Pharms. v. Kennedy WLF urges the Supreme Court to review the Inflation Reduction Act’s Medicare Drug Price Negotiation Program. [rule of law] Montgomery v. Caribe WLF asks the Supreme Court...

A Supreme Court ruling on a conflict between federal and state procedural rules could complicate plaintiffs' use of state anti-SLAPP statutes in federal court.